evolcSign inStart free
Menu

Tamrisa

Develops antibiotics and supplies established anti-infective medicines for patients and healthcare markets

Paris, FranceFounded 2023tamrisa.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2023
  • New on EvolcAdded 2026-11-10

About Tamrisa

Tamrisa is a pharmaceutical venture developing dabocins, a new class of antibacterials, for drug-resistant bacterial infections. Its pipeline includes two programs targeting carbapenem-resistant pathogens, alongside a portfolio of established antibiotics and other anti-infective medicines.

The company distributes its existing medicines through partners and works with manufacturing partners to support their supply. Its R&D team is located near Paris and collaborates with AMR experts and partners internationally.

TAMRISA is a French SAS founded in 2023 and headquartered in Paris. Its development programs have received support from CARB-X, Novo Holdings REPAIR Impact Fund and Roche.

Product: Develops investigational antibiotics and distributes established antibiotics and other anti-infective medicines through partners.

Jobs at Tamrisa

No open positions listed right now.

More biotech & pharma companies

  • Tebu Bio

    Life sciences products, CRO research services and procurement solutions for researchers across Europe
    Le Perray-en-Yvelines, FranceBiotech & pharmaFounded 1974
    New on Evolc

  • Tedis

    Pharmaceutical wholesale distributor linking laboratories with pharmacies and hospitals in France and export markets in Africa and Asia
    FranceBiotech & pharma1 open job
    Salary transparent

  • Terratis

    Sterile-insect mosquito control services for French municipalities and other high-traffic public areas
    Montpellier, FranceBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Thea Open Innovation

    Ophthalmology innovation partnerships and investment for startups, researchers and companies developing eye-care treatments
    Clermont-Ferrand, FranceBiotech & pharmaFounded 2018
    New on Evolc

  • Theravectys

    Lentiviral vector vaccine candidates for cancers and chronic infectious diseases, developed with Institut Pasteur
    Evry-Courcouronnes, FranceBiotech & pharmaFounded 2005
    New on Evolc

  • Tissium

    Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical use
    Paris, FranceBiotech & pharmaFounded 20134 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Frontend frameworks

  • NuxtHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • VueMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • ApacheHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.